Prostate cancer awareness webinar

An enlightening and empowering webinar dedicated to raising awareness about prostate cancer. Prostate cancer is the second most common cancer among men worldwide, but with early detection and informed decisions, we can make a significant difference in the lives of those affected.

Dr Hope Simiyu of Tibu Health provides valuable insights and information throughout the webinar, ensuring you leave with a better understanding of prostate cancer, the importance of early detection, and the resources available for support.

Webinar Questions

  1. Is prostate cancer hereditary?

Prostate cancer can have a hereditary component, but it’s not solely determined by genetics. Family history and genetics can play a role in the risk of developing prostate cancer, but environmental factors also contribute to the overall risk. It’s important to note that having a family history or genetic mutations associated with prostate cancer does not guarantee that an individual will develop the disease. Many men with a family history or genetic predisposition do not develop prostate cancer. Conversely, some men without a family history or known genetic mutations can still develop the disease.

  1. Can prostate Cancer lead to impotence?

Prostate cancer just like any other cancer can lead to complications in the advanced stages. Some of the common complications include;

  • Spread to distant organs such as bones (Metastasis)
  • Urinary incontinence
  • Erectile dysfunction (impotence)
  1. Is a higher frequency of urination (even though justified) a warning sign for prostate cancer?

If it is justified, it should not be a cause for concern. However it’s important to note that these urinary symptoms can also be caused by non-cancerous conditions, such as benign prostatic hyperplasia (BPH) or urinary tract infections. Nevertheless, if you experience any of these symptoms, it’s essential to consult with a healthcare provider for a proper evaluation, especially if you are at a higher risk for prostate cancer due to family history or other factors.

  1. What is the level of Prostate cancer treatment in Kenya compared to the UK?

The level of prostate cancer treatment in Kenya compared to the UK varies significantly in terms of access to advanced medical facilities, technology, healthcare infrastructure, and resources. Here are some key differences to consider:

  •  Healthcare Infrastructure and Resources:

The UK has a well-established healthcare system with a robust infrastructure that includes specialised cancer centres, hospitals, and medical facilities dedicated to cancer care.In Kenya, the healthcare system faces challenges related to infrastructure, funding, and resources. While there are healthcare facilities that provide cancer care, they may have limited access to advanced technology and expertise.

  • Access to Screening and Early Detection:

In the UK, routine prostate cancer screenings, including prostate-specific antigen (PSA) tests and digital rectal exams (DREs), are offered to eligible individuals as part of the National Health Service (NHS) screening programs. In Kenya, access to routine prostate cancer screening can be limited, especially in rural areas. Screening programs may not be as widespread or accessible to the general population.

  • Treatment Options:

The UK offers a wide range of treatment options for prostate cancer, including surgery, radiation therapy, hormone therapy, chemotherapy, immunotherapy, and targeted therapy. The choice of treatment is based on the specific case and the patient’s overall health. In Kenya, treatment options for prostate cancer are available, but the availability of advanced treatments, such as robotic surgery and highly specialised targeted therapies, may be limited. Access to certain treatments may depend on factors like location and financial resources.

  • Expertise and Medical Personnel:

The UK has a large pool of experienced oncologists, urologists, radiologists, and other healthcare professionals specialising in prostate cancer care. Multidisciplinary teams collaborate to provide comprehensive care. In Kenya, there is a shortage of specialised oncologists and urologists, which can affect the availability of expert care. Patients may need to travel to major cities for specialised treatment.

  • Research and Clinical Trials:

The UK has a robust research infrastructure and participates in clinical trials, which offer access to cutting-edge treatments and therapies through clinical research. While Kenya has made progress in clinical research, it may have limited participation in global clinical trials for prostate cancer treatments.

  1. Where are the best places to go to get screened in Kenya?

In Kenya, you can get screened for prostate cancer at various healthcare facilities, including public hospitals, private clinics, and specialised cancer centres. The best place for prostate cancer screening depends on your location, financial resources, and personal preferences.

  1. Why is it important to screen for prostate cancer for men above the age of 40?

Screening for prostate cancer in men aged 40 and above is crucial for several reasons. Firstly, it facilitates early detection of prostate cancer, which often develops slowly and may not show symptoms in its initial stages. This early detection can lead to better treatment outcomes. Secondly, it assesses an individual’s prostate cancer risk based on factors like family history and ethnicity, enabling personalised care plans. Early detection also offers a wider range of treatment options, potentially reducing the need for aggressive interventions and preserving a higher quality of life. Moreover, studies have indicated higher survival rates for prostate cancer diagnosed at an early stage. Regular screening provides peace of mind and opportunities for preventive measures, such as lifestyle changes. Lastly, it connects patients with essential support resources, including counselling and support groups. However, the decision to undergo screening should be made in consultation with a qualified healthcare provider, considering individual risk factors and preferences.

  1. What is covered by insurance?

If your policy includes health screening then a prostate screening test is usually included, although there may be a limitation due to age, for example, the test is only available for men over 50. You also need to bear in mind that a waiting period often applies to health checks/screenings, so that needs to have been exhausted before having the check/screen. It is always best to check the detailed policy wording on what is and what is not covered.

If your policy includes outpatient cover, and you have symptoms, then the policy will cover the cost of getting the symptoms checked out, tested and diagnosed.

If the diagnosis warrants outpatient treatment, for example prescribed drugs, then that could be covered under the outpatient benefits if prescribed drugs are covered.

If the diagnosis warrants inpatient or day patient hospital treatment, then that would be covered under the inpatient benefits.